BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28952293)

  • 1. MIR-92 stimulates VEGF by inhibiting von Hippel-Lindau gene product in epithelial ovarian cancer.
    Guo FJ; Shao YP; Wang YP; Jin YM; Liu SS; Wang QY
    J Biol Regul Homeost Agents; 2017 Jul-Sep,; 31(3):615-624. PubMed ID: 28952293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of von Hippel-Lindau increases ovarian cancer cell aggressiveness through the HIF1α/miR-210/VMP1 signaling pathway.
    Liu T; Zhao L; Chen W; Li Z; Hou H; Ding L; Li X
    Int J Mol Med; 2014 May; 33(5):1236-42. PubMed ID: 24549370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway.
    Carroll VA; Ashcroft M
    Cancer Res; 2006 Jun; 66(12):6264-70. PubMed ID: 16778202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
    Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
    Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells.
    Ghosh AK; Shanafelt TD; Cimmino A; Taccioli C; Volinia S; Liu CG; Calin GA; Croce CM; Chan DA; Giaccia AJ; Secreto C; Wellik LE; Lee YK; Mukhopadhyay D; Kay NE
    Blood; 2009 May; 113(22):5568-74. PubMed ID: 19336759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of hypoxia-inducible factor 1 alpha in ovarian clear cell carcinoma.
    Lee S; Garner EI; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2007 Aug; 106(2):311-7. PubMed ID: 17532031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
    Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
    Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA‑566 modulates vascular endothelial growth factor by targeting Von Hippel‑Landau in human glioblastoma in vitro and in vivo.
    Xiao B; Zhou X; Ye M; Lv S; Wu M; Liao C; Han L; Kang C; Zhu X
    Mol Med Rep; 2016 Jan; 13(1):379-85. PubMed ID: 26572705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 regulates epithelial ovarian cancer EMT, invasion, and metastasis by modulating Let-7c and miR-200c through the STAT3/HIF-1α pathway.
    Guo QY; Song JN; Chen YM; Yuan HN; Xue WS; Sun Y; Niu XL; Wang Y; Chen X
    Med Oncol; 2024 May; 41(6):155. PubMed ID: 38744773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate.
    Merlo A; Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Pitiot AS; Balbín M; Astudillo A; Valdés N; Scola B; Del Toro R; Méndez-Ferrer S; Piruat JI; Suarez C; Chiara MD
    Oncotarget; 2017 Jan; 8(4):6700-6717. PubMed ID: 28036268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
    Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
    J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling.
    Chen L; Han L; Zhang K; Shi Z; Zhang J; Zhang A; Wang Y; Song Y; Li Y; Jiang T; Pu P; Jiang C; Kang C
    Neuro Oncol; 2012 Aug; 14(8):1026-36. PubMed ID: 22649212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cancer cells lacking hypoxia inducible factor (HIF)-1alpha expression maintain vascular endothelial growth factor expression through HIF-2alpha.
    Shinojima T; Oya M; Takayanagi A; Mizuno R; Shimizu N; Murai M
    Carcinogenesis; 2007 Mar; 28(3):529-36. PubMed ID: 16920734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
    Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
    J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells.
    Zhou J; Zhang S; Xue J; Avery J; Wu J; Lind SE; Ding WQ
    J Biol Chem; 2012 Oct; 287(42):35161-35169. PubMed ID: 22932900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of hypoxia inducible factor-1alpha on osteoblast function in osteogenesis].
    Liu XD; Deng LF; Wang J; Qi J; Zhou Q; Wang JS; Wei L; Zhu YP
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3357-61. PubMed ID: 18478952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.